NASDAQ:ADMP

Adamis Pharmaceuticals Corporation Earning Date

USA |NASDAQ |USD

ADMP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 1, 2021 Sep 2021 - - $-0.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 1, 2021 Sep 2021 - - $4.30M

Adamis Pharmaceuticals Corporation's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 2021.

ADMP Earnings Date & History Chart

ADMP Earnings & Revenue Forecast

ADMP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.17 $-0.17 $-0.17
Dec 2022 1 $-0.15 $-0.15 $-0.15

ADMP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.23 $-0.23 $-0.23
Dec 2022 0 / 0 $-0.20 $-0.20 $-0.20

ADMP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $22.00M $22.00M $22.00M
Dec 2022 1 $10.00M $10.00M $10.00M

ADMP Earnings Date & Revenue History

ADMP Earnings History

|
Show More
Show More

ADMP Revenue History

|
Show More
Show More

Adamis Pharmaceuticals Corporation Next Earnings Date & Report

ADMP Next Earnings Date & Report Preview: Sep 2021 (FQ)

ADMP's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 30, 2021.

Adamis Pharmaceuticals Corporation Previous Earnings Dates & Reports

ADMP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Adamis Pharmaceuticals Corporation's previous earnings date was Sep 27, 2021 for its fiscal quarter ended Jun 30, 2021.

ADMP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Adamis Pharmaceuticals Corporation's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

ADMP's earnings per share (EPS) was $-0.64, missing the consensus analysts forecast of $-0.45 by 42.22% , and lower than the previous year's EPS (Dec 2019) by 16.36%.

Revenues were $16.53M, worse than the forecast of $18.73M by -11.76%, and down by -25.26% from previous year's revenue.

The company reported a net income of $-49.39M.

Adamis Pharmaceuticals Corporation reported a free cash flow of $-21.85M for its fiscal year, compared to $-22.75M a year ago.

The company ended the fiscal year with $5.75M in total debt, an increase of 41.05% compared to the previous year.